Utilization of 111In-Capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy

International Journal of Urology

Volumn 16, Issue 12, 2009, Pages 971-975

  Kimura, Masaki ^a   Tsivian, Matvey ^a   Mouraviev, Vladimir ^a   Mayes, Janice M ^a   Price, Marva M ^a   Bannister, Michael C ^a   Madden, John F ^b   Wong, Terence Z ^b   Polascik, Thomas J ^a  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

111In capromab pendetide scan; In situ therapy; Prostate cancer; Recurrence; Seminal vesicle invasion

Indexed keywords

ANTIANDROGEN; CAPROMAB PENDETIDE IN 111;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRYOTHERAPY; DIAGNOSTIC VALUE; DRUG UPTAKE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SEMINAL VESICLE DISEASE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; DATABASES, FACTUAL; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEMINAL VESICLES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70450267372     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02413.x     Document Type: Article

References (22)

1. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 2008 112 : 307 314.
2. Zelefsky MJ, Kuban DA, Levy LB et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int. J. Radiat. Oncol. Biol. Phys. 2007 67 : 327 333.
3. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002 60 : 3 11.
4. Pucar D, Sella T, Schoder H. The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery. Curr. Opin. Urol. 2008 18 : 87 97.
5. Tempany CM, Zhou X, Zerhouni EA et al. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology 1994 192 : 47 54.
6. Wolf JS Jr., Cher M, Dall'era M, Presti JC Jr., Hricak H, Carroll PR. The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J. Urol. 1995 153 : 993 999.
7. Lau HY, Kindrachuk G, Carter M et al. Surgical confirmation of ProstaScint abnormalities in two patients with high risk prostate cancer. Can. J. Urol. 2001 8 : 1199 1202.
8. Raj GV, Partin AW, Polascik TJ. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy. Cancer 2002 94 : 987 996.
9. Sodee DB, Ellis RJ, Samuels MA et al. Prostate cancer and prostate bed SPECT imaging with ProstaScint: semiquantitative correlation with prostatic biopsy results. Prostate 1998 37 : 140 148.
10. Sodee DB, Nelson AD, Faulhaber PF, Maclennan GT, Resnick MI, Bakale G. Update on fused capromab pendetide imaging of prostate cancer. Clin. Prostate Cancer 2005 3 : 230 238.
11. Schettino CJ, Kramer EL, Noz ME, Taneja S, Padmanabhan P, Lepor H. Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer. AJR Am. J. Roentgenol. 2004 183 : 519 524.
12. Ellis RJ, Zhou EH, Fu P et al. Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure. J. Urol. 2008 179 : 1768 1773 discussion 73-4.
13. Consensus statement; guidlines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int. J. Radiat. Oncol. Biol. Phys. 1997 37 : 1035 1041.
14. Greene FL, Page DL, Fleming ID. AJCC Cancer Staging Manual, 6th edn. Springer Verlag, New York, 2002.
15. Crook J, Malone S, Perry G, Bahadur Y, Robertson S, Abdolell M. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int. J. Radiat. Oncol. Biol. Phys. 2000 48 : 355 367.
16. Wong TZ, Turkington TG, Polascik TJ, Coleman RE. ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology. AJR Am. J. Roentgenol. 2005 184 : 676 680.
17. Polascik TJ, Manyak MJ, Haseman MK et al. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients. Cancer 1999 85 : 1586 1592.
18. Koontz BF, Mouraviev V, Johnson JL et al. Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008 71 : 358 361.
19. Proano JM, Sodee DB, Resnick MI, Einstein DB. The impact of a negative (111)indium-capromab pendetide scan before salvage radiotherapy. J. Urol. 2006 175 : 1668 1672.
20. Nagda SN, Mohideen N, Lo SS et al. Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2007 67 : 834 840.
21. Jung DC, Lee HJ, Kim SH, Choe GY, Lee SE. Preoperative MR imaging in the evaluation of seminal vesicle invasion in prostate cancer: pattern analysis of seminal vesicle lesions. J. Magn. Reson. Imaging 2008 28 : 144 150.
22. Terris MK, McNeal JE, Freiha FS, Stamey TA. Efficacy of transrectal ultrasound-guided seminal vesicle biopsies in the detection of seminal vesicle invasion by prostate cancer. J. Urol. 1993 149 : 1035 1039.